Literature DB >> 6493188

[Experimental studies of hyperthermia against MH134 tumor on mice. Antitumor effects under various conditions of heating].

Y Matsuzaki.   

Abstract

The antitumor effects of local hyperthermia on MH134 tumor inoculated on mice under various conditions of heating were studied. 2 X 10(5) cells of MH134 were inoculated on the hind limbs of mice. The tumor was heated in a water bath at different temperatures, onsets, durations, times and intervals. The tumor growth rate, survival time, the degree of lymph node involvement and histological damage of heated tumors and normal tissue were examined in comparison with untreated tumors. The following results were obtained. Normal tissue received irreversible damage under conditions of either 45 degrees C, over 30 min. or 42 degrees C, over 240 min. Antitumor effects were observed significantly in the following conditions compared with untreated group. 1) temperature: 42 degrees C, 2) onset of hyperthermia: within the 20th day after inoculation, 3) duration of hyperthermia: over 30 min., 4) times of hyperthermia: twice or more, 5) interval of hyperthermia: over 48 hrs. Thermotolerance was induced when the interval of hyperthermia was less than 24 hrs. This tolerance was considered to be clinically important. Local lymph node metastasis was suppressed in the early stage of hyperthermia. Systemic lymph node metastasis, however, was found with the passage of time in all groups of hyperthermia.

Entities:  

Mesh:

Year:  1984        PMID: 6493188

Source DB:  PubMed          Journal:  Nihon Geka Gakkai Zasshi        ISSN: 0301-4894


  2 in total

1.  Thermotolerance in regional hyperthermia in vivo--an experimental study using the MH134 tumor.

Authors:  Y Matsuzaki; M Yoshioka; T Yonezawa; T Onitsuka; K Shibata; Y Koga
Journal:  Jpn J Surg       Date:  1991-01

2.  Plasma-activated medium as adjuvant therapy for lung cancer with malignant pleural effusion.

Authors:  Yi-Jing Cheng; Ching-Kai Lin; Chao-Yu Chen; Po-Chien Chien; Ho-Hsien Chuan; Chao-Chi Ho; Yun-Chien Cheng
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.